Mirati Therapeutics Inc. buy Stifel Nicolaus
Start price
06.10.23
/
50%
€56.84
Target price
06.10.24
€78.43
Performance (%)
-5.00%
End price
07.10.24
-
Summary
This prediction is currently being closed. With a performance of -5.00%, the BUY prediction for Mirati Therapeutics Inc. by Stifel_Nicolaus is down slightly. Stifel_Nicolaus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Mirati Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 3,59 % | 3,93 % | 15,38 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % | 41,46 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % | 48,95 % |
| iShares S&P 500 | 4,14 % | 4,04 % | 31,59 % |
Comments by Stifel_Nicolaus for this prediction
In the thread Mirati Therapeutics Inc. diskutieren
Mirati Therapeutics, Inc. (NASDAQ: MRTX) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $83.00 price target on the stock.
Ratings data for MRTX provided by MarketBeat
In the thread Trading Mirati Therapeutics Inc.
Die von Stifel_Nicolaus gewählte maximale Laufzeit wurde überschritten